Clinical trials
Completed Testicular Neoplasms trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 3 |
| Eastern Cooperative Oncology Group | 2 |
| Aarhus University Hospital | 1 |
| Agri Ibrahim Cecen University | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Brigham and Women's Hospital | 1 |
| Children's Oncology Group | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Eastern Mediterranean University | 1 |
| Haukeland University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Testicular Neoplasms | 35 |
| Breast Neoplasms | 14 |
| Hodgkin Disease | 13 |
| Lymphoma, Non-Hodgkin | 12 |
| Burkitt Lymphoma | 11 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 11 |
| Lymphoma, B-Cell, Marginal Zone | 11 |
| Lymphoma, Follicular | 11 |
| Lymphoma, Large B-Cell, Diffuse | 11 |
| Lymphoma, Large-Cell, Immunoblastic | 11 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.